Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Sudhir Tauro is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Part-Time Data Co-ordinator and Research Nurse in Haematology
Tauro, S. (Investigator)
Project: Research
-
Dissecting The Potential For GSK3 Inhibition To Improve Lymphoma Treatment
Sutherland, C. (Investigator) & Tauro, S. (Investigator)
Project: Research
-
Pharmacogenomic Approaches To Precision Medicine In Acute Myeloid Leukaemia - The Genomic Determinants Of Toxicity In Acute Promyelocytic Leukaemia Patients Treated With Arsenic Trioxide And All Trans Retinoic Acid
Palmer, C. (Investigator), Srinivasan, S. (Investigator) & Tauro, S. (Investigator)
1/08/23 → 31/10/24
Project: Research
-
Cellular Responses to Bendamustine in Chronic Lymphocytic Leukaemia
Clarke, P. (Investigator), Rastogi, S. (Investigator) & Tauro, S. (Investigator)
1/07/14 → 30/11/14
Project: Research
-
Characterisation of the Anti-Leukaemic Effects of Tenovin-6 in Chronic Lymphocytic Leukaemia
Ganley, I. (Investigator) & Tauro, S. (Investigator)
1/08/12 → 31/01/15
Project: Research
-
The enzyme Glycogen Synthase Kinase-3 is associated with specific forms of oncogenesis: what more do we need to know to achieve clinical benefit?
Sutherland, C. (Lead / Corresponding author), Harrower, R., Coats, J. & Tauro, S., Sept 2025, In: Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880, 4, 16 p., 189365.Research output: Contribution to journal › Review article › peer-review
Open AccessFile43 Downloads (Pure) -
Elraglusib Induces Cytotoxicity via Direct Microtubule Destabilization Independently of GSK3 Inhibition
Coats, J. (Lead / Corresponding author), Li, S., Tanaka, T., Tauro, S., Sutherland, C. & Saurin, A. T. (Lead / Corresponding author), Nov 2024, In: Cancer Research Communications. 4, 11, p. 3013-3024 12 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Citations (Scopus)42 Downloads (Pure) -
Shaping the AML Treatment Landscape: Modeling a Path through Plenty, Uncertainty, and Paucity
Hodgkinson, A. & Tauro, S. (Lead / Corresponding author), 30 Apr 2024, (E-pub ahead of print) In: Journal of Health and Allied Sciences NU. 14, 2, p. 149-151 3 p.Research output: Contribution to journal › Editorial › peer-review
Open AccessFile25 Downloads (Pure) -
Elraglusib (formerly 9-ING-41) possesses potent anti-lymphoma properties which cannot be attributed to GSK3 inhibition
Coats, J. T., Tauro, S. & Sutherland, C. (Lead / Corresponding author), 14 Jun 2023, In: Cell Communication and Signaling. 21, 7 p., 131.Research output: Contribution to journal › Article › peer-review
Open AccessFile6 Citations (Scopus)144 Downloads (Pure) -
Frontline Management of Acute Myeloid Leukaemia Eligible for Intensive Chemotherapy
Tauro, S. & Russell, N. H., 28 Sept 2023, Pathogenesis and Treatment of Leukemia. Gill, H. & Kwong, Y.-L. (eds.). Springer Nature, p. 91-110 20 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
Open AccessFile22 Downloads (Pure)